Literature DB >> 8539323

Cognitive and EEG recovery following bolus intravenous administration of anesthetic agents.

S La Marca, R J Lozito, R W Dunn.   

Abstract

Bolus intravenous (IV) administration of commonly used IV anesthetic agents such as fentanyl and the fentanyl analogues, alfentanil, remifentanil, and sufentanil, etomidate and propofol, produced anesthesia in rats as measured by the loss of righting (LOR) with calculated ED150 doses of 0.06, 0.09, 0.037, 0.007, 2.51 and 6.12 mg/kg, respectively. Animals trained in an eight arm radial maze (RAM) were assessed for cognitive recovery, as measured by response efficiency (percentage of correct arm entries within 10 min), immediately, 15 min and 30 min following IV administration of the calculated ED150 dose of each of these agents, and the subsequent return of righting (ROR). Animals administered fentanyl or sufentanil were unable to successfully complete the maze throughout the testing periods. Animals receiving remifentanil showed cognitive recovery within the first testing interval (immediately following the return of righting), while animals receiving alfentanil, etomidate or propofol showed recovery at the 15-min testing interval following ROR. In a separate experiment, bolus IV administration of the ED150 dose of these agents was evaluated in an acute rat EEG model. Following ROR, return to baseline EEG levels occurred at 0.30, 2.88, 5.06, 16.25, 31.29 and 43.98 min for remifentanil, propofol, alfentanil, etomidate, fentanyl and sufentanil, respectively. These data show that the return to efficient cognitive functioning corresponds to the return to normal baseline EEG waveforms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8539323     DOI: 10.1007/bf02245814

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

Review 1.  Electroencephalogram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs.

Authors:  J W Mandema; M Danhof
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

Review 2.  Molecular and cellular mechanisms of general anaesthesia.

Authors:  N P Franks; W R Lieb
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

3.  Etomidate: a clinical and electroencephalographic comparison with thiopental.

Authors:  M M Ghoneim; T Yamada
Journal:  Anesth Analg       Date:  1977 Jul-Aug       Impact factor: 5.108

4.  Sedative doses of propofol increase beta activity of the processed electroencephalogram.

Authors:  H A Seifert; R T Blouin; P F Conard; J B Gross
Journal:  Anesth Analg       Date:  1993-05       Impact factor: 5.108

5.  Power spectral analysis of the electroencephalographic and hemodynamic correlates of propofol anesthesia in the rat: intravenous bolus administration.

Authors:  M H Shyr; C H Yang; T B Kuo; W H Pan; P P Tan; S H Chan
Journal:  Neurosci Lett       Date:  1993-04-30       Impact factor: 3.046

6.  Comparison of the sedative and amnesic effects of midazolam and propofol.

Authors:  M R Polster; P A Gray; G O'Sullivan; R A McCarthy; G R Park
Journal:  Br J Anaesth       Date:  1993-06       Impact factor: 9.166

7.  Plasma concentration and E.E.G. after various regimens of etomidate.

Authors:  A Doenicke; B Löffler; J Kugler; H Suttmann; B Grote
Journal:  Br J Anaesth       Date:  1982-04       Impact factor: 9.166

Review 8.  GABAA receptor modulation of memory: the role of endogenous benzodiazepines.

Authors:  I Izquierdo; J H Medina
Journal:  Trends Pharmacol Sci       Date:  1991-07       Impact factor: 14.819

9.  Electroencephalographic study of the short-acting hypnotics etomidate and methohexital in dogs.

Authors:  A Wauquier; W A van den Broeck; J L Verheyen; P A Janssen
Journal:  Eur J Pharmacol       Date:  1978-02-15       Impact factor: 4.432

10.  EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil.

Authors:  J C Scott; K V Ponganis; D R Stanski
Journal:  Anesthesiology       Date:  1985-03       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.